Max pain is the price where the total value of all open calls and puts would be lowest at expiration, so option buyers as a group would lose the most. Some traders watch it as a level the stock may drift toward near expiration, because option sellers, often market makers, hedge their positions in ways that can pull the price toward heavily traded strikes. It is a theory, not a guarantee.

As of the Nov 4, 2026 close, max pain for Beam Therapeutics options about one week from expiration was $23.98. The chart above shows the exact max pain for each expiration date.

Beam Therapeutics closed above its near-term max pain on 13 of the last 20 trading days. On Nov 4, 2026 it closed at $27.80, 15.9% above max pain of $23.98.

Over the last 20 trading days, near-term max pain for Beam Therapeutics ranged from $23.70 to $25.00. It went from $24.99 on Oct 8, 2026 to $23.98 on Nov 4, 2026. See the BEAM max pain history for a longer view.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases.